title: Vaccination and inflammatory arthritis: overview of current vaccines and recommended uses in rheumatology.
abstract: Patients with autoimmune inflammatory rheumatic diseases are prone to infectious complications during the course of their disease. The underlying disease with an impaired immune system and additional different immunosuppressive medication render patients more susceptible to infections, some of which are potentially preventable with vaccination. Since it is not clear how strongly the underlying and medication-induced immunosuppression interferes with vaccination, a lot of questions remain about its indications, efficacy and safety . Due to these unresolved questions, in 2011, EULAR published general guidelines about vaccination in patients with autoimmune rheumatic diseases. These guidelines provide a basis for patient care and are also the basis of the following review article. With more available and earlier used immunosuppressive medications, a lot of questions still remain about optimal use of vaccines, the role of different medication combinations on efficacy and safety of vaccinations especially of the actual prevention of disease, the role of age, gender, disease activity and duration, and optimal revaccination schedules in this patient group. Actual studies elute the role of different medication combinations on efficacy and safety mainly addressing influenza and pneumococcal vaccination. In addition, interesting new data on basic immunological processes during TNF-α-blockade open up questions for further research.
authors: Department of Clinical Immunology and Rheumatology Kerckhoff Clinic Bad Nauheim, Justus-Liebig-University Giessen, Benekestrasse 2, 61231, Bad Nauheim, Germany.
authors: Claudia
authors: C
authors: Müller-Ladner
authors: Ulf
authors: U
authors: Müller-Ladner
mesh_terms: D001168:Arthritis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D000075202:Contraindications; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000150:complications / Q000276:immunology / Q000517:prevention & control; D008297:Male; D011008:Pneumococcal Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000379:methods; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D014613:Vaccines, Attenuated
references: Tohoku J Exp Med. 2013;229(1):29-34
references: 23221145
references: J Rheumatol. 2010 Feb;37(2):330-40
references: 20032093
references: Rheumatol Int. 2012 Jun;32(6):1533-9
references: 21327432
references: Rheumatology (Oxford). 2009 Feb;48(2):144-8
references: 19074187
references: Arthritis Rheum. 2013 Jan;65(1):39-47
references: 23044506
references: Arthritis Rheum. 2011 Oct;63(10):3032-7
references: 21953088
references: Ann Rheum Dis. 2012 Dec;71(12):2006-10
references: 22887851
references: Rheumatology (Oxford). 2012 Apr;51(4):695-700
references: 22171015
references: Ann Rheum Dis. 2013 Aug;72(8):1362-6
references: 23345600
references: Lupus. 2012 Feb;21(2):158-61
references: 22235047
references: Arthritis Care Res (Hoboken). 2010 Jul;62(7):1034-9
references: 20235203
references: Ann Rheum Dis. 2012 Jun;71(6):948-54
references: 22172491
references: MMWR Morb Mortal Wkly Rep. 2012 Jul 20;61(28):541
references: 22810269
references: Clin Rheumatol. 2011 May;30(5):665-72
references: 21072553
references: Arthritis Res Ther. 2013 Jan 04;15(1):R1
references: 23286772
references: Rheumatol Int. 2013 Feb;33(2):335-40
references: 22451033
references: Ann Rheum Dis. 2013 May;72(5):659-64
references: 22589375
references: Lupus. 2010 Nov;19(13):1485-91
references: 20605875
references: Clin Rheumatol. 2011 Dec;30(12):1555-61
references: 21956234
references: Rheumatology (Oxford). 2012 Nov;51(11):2091-8
references: 22908326
references: Ann Rheum Dis. 2008 Jul;67(7):1047
references: 18556445
references: Ann Rheum Dis. 2011 Oct;70(10):1704-12
references: 21813547
references: Ann Rheum Dis. 2007 Oct;66(10):1384-7
references: 17284544
references: Clin Infect Dis. 2008 May 1;46(9):1459-65
references: 18419456
references: Ir Med J. 2011 Jul-Aug;104(7):208-11
references: 21957688
references: Ann Rheum Dis. 2002 Jul;61(7):623-5
references: 12079904
references: J Clin Rheumatol. 2012 Aug;18(5):237-41
references: 22832287
references: Arthritis Rheum. 2010 Jan;62(1):64-74
references: 20039397
references: Arthritis Rheum. 2011 Dec;63(12):3723-32
references: 21834061
references: Ann Rheum Dis. 2011 Mar;70(3):414-22
references: 21131643
references: J Rheumatol. 2007 May;34(5):952-7
references: 17444589